Literature DB >> 9233636

Time-dependent induction of protective anti-influenza immune responses in human peripheral blood lymphocyte/SCID mice.

S E Albert1, C McKerlie, A Pester, B J Edgell, J Carlyle, M Petric, J W Chamberlain.   

Abstract

The human (hu) PBL/SCID mouse model has the potential to provide a powerful tool for the study of human immune function. However, at peak engraftment (4-8 wk postinjection), recovered human T cells are largely unresponsive to foreign Ag and have converted to an activated/memory-type phenotype. Here we show that this conversion is not a prerequisite for engraftment because at early stages (2 wk) a substantial fraction of human T cells detected in SCID peripheral blood retains the unactivated/naive phenotype of donor PBL. This early stage is also associated with a TCR repertoire in both the CD4 and CD8 subsets that is similar to that in the donor. Importantly, we show that strong HLA class I allele- and peptide-specific cytotoxic T lymphocyte as well as humoral responses can be generated in this model when human cells encounter Ag (infection with influenza A) at early, but not late, stages in engraftment. This early human response was also functional, as partial protection against influenza-induced pathology and death in SCIDs was observed. Taken together, these results demonstrate that the huPBL/SCID model can support the generation of potent and specific CTL and humoral responses provided that Ag is introduced early, presumably before the time-dependent generalized xenoactivation of engrafted human cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9233636

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Transfer of human CD4(+) T lymphocytes producing beta interferon in Hu-PBL-SCID mice controls human immunodeficiency virus infection.

Authors:  V Vieillard; S Jouveshomme; N Leflour; E Jean-Pierre; P Debre; E De Maeyer; B Autran
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

2.  Antigen-specific B and T cells in human/mouse radiation chimera following immunization in vivo.

Authors:  W O Böcher; H Marcus; R Shakarchy; B Dekel; D Shouval; E Galun; Y Reisner
Journal:  Immunology       Date:  1999-04       Impact factor: 7.397

3.  Antigen-specific T cell responses in human peripheral blood leucocyte (hu-PBL)-mouse chimera conditioned with radiation and an antibody directed against the mouse IL-2 receptor beta-chain.

Authors:  T Cao; G Leroux-Roels
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

4.  Efficient generation of respiratory syncytial virus (RSV)-neutralizing human MoAbs via human peripheral blood lymphocyte (hu-PBL)-SCID mice and scFv phage display libraries.

Authors:  H Nguyen; J Hay; T Mazzulli; S Gallinger; J Sandhu; Y Teng; N Hozumi
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

5.  Mouse strain and conditioning regimen determine survival and function of human leucocytes in immunodeficient mice.

Authors:  K G Tournoy; S Depraetere; R A Pauwels; G G Leroux-Roels
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

6.  Virus-specific immunity after gene therapy in a murine model of severe combined immunodeficiency.

Authors:  K D Bunting; K J Flynn; J M Riberdy; P C Doherty; B P Sorrentino
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-05       Impact factor: 11.205

7.  Human interleukin-15 improves engraftment of human T cells in NOD-SCID mice.

Authors:  Anyuan Sun; Haiming Wei; Rui Sun; Weihua Xiao; Yongguang Yang; Zhigang Tian
Journal:  Clin Vaccine Immunol       Date:  2006-02

8.  Defective interfering influenza virus confers only short-lived protection against influenza virus disease: evidence for a role for adaptive immunity in DI virus-mediated protection in vivo.

Authors:  Paul D Scott; Bo Meng; Anthony C Marriott; Andrew J Easton; Nigel J Dimmock
Journal:  Vaccine       Date:  2011-07-14       Impact factor: 3.641

9.  Dendritic cells enhance the activity of human MUC1-stimulated mononuclear cells against breast cancer.

Authors:  Zhenyao Wang; Monte D Hall; Kathleen A Rewers-Felkins; Imelda S Quinlin; Stephen E Wright
Journal:  Oncoimmunology       Date:  2013-02-01       Impact factor: 8.110

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.